Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial
Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial
复制标题
DOI：
10.1007/s10549-020-05678-3
复制
发表时间：
2020-05-16
影响因子：
3.8
通讯作者：
Noh, Dong-Young
中科院分区：
文献类型：
--
作者：
Lee, Han-Byoel;Han, Wonshik;Noh, Dong-Young
目的利用磁共振成像（MRI）和超声（US）引导下活检准确预测乳腺癌的病理完全缓解（pCR）可能有助于选择放弃乳腺癌手术的患者。我们评估了MRI辅助下的超声引导活检预测新辅助化疗（NAC）后乳腺pCR的准确性。方法40例近pCR患者（肿瘤大小
Purpose Accurate prediction of pathologic complete response (pCR) in breast cancer using magnetic resonance imaging (MRI) and ultrasound (US)-guided biopsy may aid in selecting patients who forego surgery for breast cancer. We evaluated the accuracy of US-guided biopsy aided by MRI in predicting pCR in the breast after neoadjuvant chemotherapy (NAC). Methods After completion of NAC, 40 patients with near pCR (either tumor size